• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C5a受体上激动剂和拮抗剂肽的位点特异性二硫键捕获

Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor.

作者信息

Buck Elizabeth, Bourne Henry, Wells James A

机构信息

Sunesis Pharmaceuticals Inc., South San Francisco, California 94080, USA.

出版信息

J Biol Chem. 2005 Feb 11;280(6):4009-12. doi: 10.1074/jbc.C400500200. Epub 2004 Nov 18.

DOI:10.1074/jbc.C400500200
PMID:15550394
Abstract

The manner by which peptidic ligands bind and activate their corresponding G-protein-coupled receptors is not well understood. One of the better characterized peptidic ligands is the chemotactic cytokine complement factor 5a (C5a), a 74-amino acid helical bundle. Previous studies showed 6-mer peptide analogs derived from the C terminus of the C5a ligand can bind to C5aR (Kd values approximately 0.1-1 microm) and either agonize or antagonize the receptor (Gerber, B. O., Meng, E. C., Dotsch, V., Baranski, T. J., and Bourne, H. R. (2001) J. Biol. Chem. 276, 3394-3400). Here, we provide direct biochemical data using disulfide trapping to support a model that these peptides bind within a transmembrane helical triad formed by alpha-helices III, VI, and VII. We show that the three amino acids on the C terminus of the peptide analogs bind too weakly to exert a functional effect themselves. However, when a cysteine residue is placed on their N terminus they can be trapped by disulfide interchange to specific cysteines in helix III and VI and not to other cysteines, engineered into the C5aR. The trapped peptides function as agonists or partial antagonists, similar to the non-covalent parents from which they were derived. These data help to further refine the binding mode for C5a to the C5aR and suggest an approach and a binding site that may be applicable to studying other peptide binding receptors.

摘要

肽类配体结合并激活其相应G蛋白偶联受体的方式尚未完全明确。其中一个特征较为明确的肽类配体是趋化细胞因子补体因子5a(C5a),它是一个由74个氨基酸组成的螺旋束。先前的研究表明,源自C5a配体C末端的6聚体肽类似物能够与C5aR结合(解离常数Kd值约为0.1 - 1微摩尔),并且可以激动或拮抗该受体(格伯,B.O.,孟,E.C.,多奇,V.,巴兰斯基,T.J.,和伯恩,H.R.(2001年)《生物化学杂志》276,3394 - 3400)。在此,我们利用二硫键捕获提供了直接的生化数据,以支持这样一个模型:这些肽在由α螺旋III、VI和VII形成的跨膜螺旋三联体中结合。我们发现,肽类似物C末端的三个氨基酸自身结合力太弱,无法发挥功能作用。然而,当在其N末端放置一个半胱氨酸残基时,它们可以通过二硫键交换被捕获到螺旋III和VI中的特定半胱氨酸上,而不会与工程改造到C5aR中的其他半胱氨酸结合。捕获的肽发挥激动剂或部分拮抗剂的作用,类似于它们所衍生的非共价亲本。这些数据有助于进一步完善C5a与C5aR的结合模式,并提出一种可能适用于研究其他肽结合受体的方法和结合位点。

相似文献

1
Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor.C5a受体上激动剂和拮抗剂肽的位点特异性二硫键捕获
J Biol Chem. 2005 Feb 11;280(6):4009-12. doi: 10.1074/jbc.C400500200. Epub 2004 Nov 18.
2
Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.利用二硫键捕获技术定位G蛋白偶联受体的小分子激动剂和拮抗剂。
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2719-24. doi: 10.1073/pnas.0500016102. Epub 2005 Feb 14.
3
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.突变型人C5a受体中的激动剂/拮抗剂反应比较确定了配体结合位点。
J Biol Chem. 2005 May 6;280(18):17831-40. doi: 10.1074/jbc.M410797200. Epub 2005 Jan 20.
4
Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.
J Biol Chem. 2000 Nov 10;275(45):35393-401. doi: 10.1074/jbc.M005602200.
5
Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling.激动剂、反向激动剂和拮抗剂结合C5a受体的结构复合物:对药理学和信号传导的见解
Mol Biosyst. 2016 Apr 26;12(5):1586-99. doi: 10.1039/c6mb00031b.
6
Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
J Biol Chem. 2006 Dec 1;281(48):36783-92. doi: 10.1074/jbc.M607686200. Epub 2006 Oct 5.
7
Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.过敏毒素C5a与C5a受体结合的分子机制建模。
Biochemistry. 2008 Mar 11;47(10):3117-30. doi: 10.1021/bi702321a. Epub 2008 Feb 15.
8
Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.人C5a受体螺旋区域保守带电残基的定点诱变。精氨酸206决定C5a受体的高亲和力结合位点。
Eur J Biochem. 1996 Jan 15;235(1-2):82-90. doi: 10.1111/j.1432-1033.1996.00082.x.
9
Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.沙鼠C5a受体的分子特征及对小分子拮抗剂相互作用至关重要的跨膜结构域V氨基酸的鉴定。
J Biol Chem. 2005 Dec 9;280(49):40617-23. doi: 10.1074/jbc.M509245200. Epub 2005 Oct 17.
10
Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.补体 C5a 受体与外螺旋拮抗剂 NDT9513727 结合的结构。
Nature. 2018 Jan 3;553(7686):111-114. doi: 10.1038/nature25025.

引用本文的文献

1
Complement System Inhibitory Drugs in a Zebrafish () Model: Computational Modeling.补体系统抑制药物在斑马鱼()模型中的应用:计算建模。
Int J Mol Sci. 2023 Sep 9;24(18):13895. doi: 10.3390/ijms241813895.
2
Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.与人类补体成分受体hC5aR1结合的适体可干扰hC5aR1与其hC5a配体的相互作用。
Mol Biol Rep. 2018 Oct;45(5):851-864. doi: 10.1007/s11033-018-4231-7. Epub 2018 Jul 6.
3
Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction Networks.
小分子对蛋白质-蛋白质相互作用网络的直接和传播效应。
Front Bioeng Biotechnol. 2015 Aug 24;3:119. doi: 10.3389/fbioe.2015.00119. eCollection 2015.
4
Covalent agonists for studying G protein-coupled receptor activation.用于研究 G 蛋白偶联受体激活的共价激动剂。
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10744-8. doi: 10.1073/pnas.1410415111. Epub 2014 Jul 8.
5
FP Tethering: a screening technique to rapidly identify compounds that disrupt protein-protein interactions.荧光蛋白拴系:一种快速鉴定破坏蛋白质-蛋白质相互作用化合物的筛选技术。
Medchemcomm. 2014 Mar 1;5:370-375. doi: 10.1039/C3MD00356F.
6
Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.VUF14480 的设计与药理学特性:一种与人类组氨酸 H₄ 受体半胱氨酸 98(3.36)相互作用的共价部分激动剂。
Br J Pharmacol. 2013 Sep;170(1):89-100. doi: 10.1111/bph.12113.
7
Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping.利用半胱氨酸捕获技术绘制分泌素氨基末端与受体各胞外环之间的空间近似图。
FASEB J. 2012 Dec;26(12):5092-105. doi: 10.1096/fj.12-212399. Epub 2012 Sep 10.
8
Turning a protein kinase on or off from a single allosteric site via disulfide trapping.通过二硫键捕获,从单一变构位点打开或关闭蛋白激酶。
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6056-61. doi: 10.1073/pnas.1102376108. Epub 2011 Mar 23.
9
Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.第三细胞外环(EC3)-N 端相互作用对七跨膜域受体功能很重要:对激活微开关区域的影响。
J Biol Chem. 2010 Oct 8;285(41):31472-83. doi: 10.1074/jbc.M110.129213. Epub 2010 Jul 27.
10
Mapping peptide hormone-receptor interactions using a disulfide-trapping approach.使用二硫键捕获方法绘制肽激素-受体相互作用图谱。
Biochemistry. 2008 Jun 3;47(22):5889-95. doi: 10.1021/bi800122f. Epub 2008 May 7.